Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen on patients undergoing thyroidectomy and parathyroidectomy.


Clinical Trial Description

The purpose of this study is to evaluate the use of a non-narcotic, postoperative pain management regimen for patients undergoing thyroidectomy and parathyroidectomy. The investigators hypothesize that participants receiving non-narcotic pain regimens will have equivalent pain control and satisfaction to those who receive narcotic pain medicines.

The primary objective will be to identify if there is a difference in average perceived postoperative pain scores between participants who do and do not receive narcotic pain medications. Secondary outcomes will include need for breakthrough pain medications, patient satisfaction scores and the need to call the surgeon office for additional pain medications.

The participant will undergo total thyroidectomy, partial thyroidectomy or parathyroidectomy per the standard of care. The study will have no influence on the surgical procedure performed.

Following the surgery, postoperative analgesia regimens will be prescribed based on study randomization.

Narcotic group regimen (63 patients):

- Tylenol tablet 1000 mg by mouth every 8 hours alternating with

- Ibuprofen tablet 800 mg by mouth every 8 hours

- Oxycodone 5 mg by mouth every 6 hours as needed for pain, #10 tablets

Non-narcotic group regimen (63 patients):

- Tylenol tablet 1000 mg by mouth every 8 hours alternating with

- Ibuprofen tablet 800 mg by mouth every 8 hours

Participants will be asked to complete a survey each day for the initial 5 days postoperatively. Survey data includes:

- Average pain level using the 10-point visual analogue scale

- Ease of following the pain regimen using a 3-point liker scale

- Total dose of oral narcotics converted into oral morphine equivalents that were taken by participants post-operatively

- If the patient needed to call the office due to inadequately controlled pain

If the participants do not have adequate pain control with the non-narcotic regimen, they may be prescribed additional narcotic pain medication at the discretion of the PI and remain enrolled in the study.

The investigators will also review participants charts for information regarding any postoperative office calls regarding postoperative needs (i.e. for pain medications).

The medical surgical information below is gathered as standard of care for each surgical procedure and will also be collected as part of this procedure:

- Patient name, medical record number

- Patient demographics (age, gender, BMI, ASA score)

- Past medical History

- Past surgical history

- Past social history

- Preoperative medications (including steroids, anticoagulation, opioid use)

- Pre-operative diagnosis

- Procedure performed and pain medications administered in the post-ambulatory care unit

- Postoperative complications including need for readmission within 30 days

- Length of stay in hospital ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03640247
Study type Interventional
Source MetroHealth Medical Center
Contact
Status Completed
Phase Phase 1
Start date November 15, 2018
Completion date December 1, 2019

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05836246 - The Development of Quantitative Ultrasound Imaging Software Platform
Active, not recruiting NCT05579782 - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy N/A
Completed NCT04124705 - A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants Phase 2
Enrolling by invitation NCT06028282 - Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing
Recruiting NCT05626010 - Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy N/A
Completed NCT01805856 - Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery N/A
Recruiting NCT05117853 - Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy Phase 3
Completed NCT00592605 - Thyroid Disease Serum Repository N/A
Completed NCT04344886 - Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery N/A
Completed NCT03012438 - NIRF for Parathyroid Visualization: a Pilot Study N/A
Completed NCT00846755 - Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening N/A
Completed NCT04635813 - The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study
Not yet recruiting NCT05432050 - Bispectral Index and Patient State Index During General Anesthesia With Remimazolam
Recruiting NCT03191188 - A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients N/A
Recruiting NCT06296420 - Dysphagia After Thyroidectomy
Completed NCT02981095 - Effect of Bupivacaine Application on Postthyroidectomy Pain N/A
Completed NCT01539499 - Complications of Endocrine Surgery: Data From the United HealthSystem Consortium N/A
Completed NCT05421559 - Transection of Sternothyroid Muscle Increases the Rate of Exposure of the External Laryngeal Nerve During Thyroidectomy N/A
Completed NCT00054756 - Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities Phase 2
Completed NCT02951000 - Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery N/A